Virus infection and clotting factor concentrates
Rubinstein, D.B.
Lancet 345(8959): 1248
1995
ISSN/ISBN: 0140-6736 PMID: 7739339 Document Number: 451148
Document emailed within 1 workday
Related Documents
Mariani, G.; Di Nucci, G.D.; Arcieri, P. 1994: Immunopurified clotting factor concentrates Nouvelle Revue Francaise d'Hematologie 36(Suppl 1): S61-S65Köller, U.; Majdic, O.; Liszka, K.; Stockinger, H.; Pabinger-Fasching, I.; Lechner, K.; Knapp, W. 1985: Lymphocytes of haemophilia patients treated with clotting factor concentrates display activation-linked cell-surface antigens Clinical and Experimental Immunology 59(3): 613-621
Preston, F.E.; Malia, R.G.; Lilleyman, J.S.; Blackburn, E.K. 1977: Heparinised clotting factor concentrates in patients with Christmas disease and liver disease Thrombosis and Haemostasis 38(2): 504-509
Hemker, H.C.; Kop, J.; Willems, G.M. 1979: Kinetic aspects of the interaction of blood clotting enzymes. VIII. the relation between clotting time and clotting velocity Thrombosis and Haemostasis 41(2): 309-313
Rosén, S. 2001: A rebuttal: Issues with the assay of factor VIII activity in plasma and factor VII concentrates Thrombosis and Haemostasis 86(4): 1132-1133
Hofmann, V.; Ermanni, M.; Straub, P.W. 1978: Thrombin formation in factor IX concentrates and FEIBA (factor eight inhibitor bypassing activity) (proceedings) Schweizerische Medizinische Wochenschrift 108(41): 1600
Allain, J.P. 1972: Study of the "in vivo" activity of factor VIIi or factor IX after injection of several concentrates: practical applications Nouvelle Revue Francaise d'Hematologie 12(2): 241-249
Anuradha, K.; Singh, H.M.; Gopal, K.V.T.; Rama Rao, G.R.; Ramani, T.V.; Padmaja, J. 2008: Herpes simplex virus 2 infection: a risk factor for HIV infection in heterosexuals Indian Journal of Dermatology Venereology and Leprology 74(3): 230-233
Lee, C.A.; Owens, D.; Bray, G.; Giangrande, P.; Collins, P.; Hay, C.; Gomperts, E.; Schroth, P.; Barrowcliffe, T. 1999: Pharmacokinetics of recombinant factor VIIi (recombinate) using one-stage clotting and chromogenic factor VIIi assay Thrombosis and Haemostasis 82(6): 1644-1647
Escolar, G.; Carretero, M.; Magallón, M.; Quintana, M.; Arnau, C.; Castillo, R.; Aznar-Salatti, J. 1998: von Willebrand factor contained in factor VIII concentrates of different purities supports platelet adhesion in blood samples from a heterogeneous group of patients with von Willebrand disease Haematologica 83(11): 1009-1014
Nyman, D. 1975: Clinical use of factor IX concentrates Schweizerische Medizinische Wochenschrift 105(37): 1188-1190
Saves, M.; Raffi, F.; Clevenbergh, P.; Marchou, B.; Waldner-Combernoux, A.; Morlat, P.; LeMoing, V.; Riviere, C.; Chene, G.; Leport, C.; The APROCOStudy Group, 2000: Hepatitis B or Hepatitis C Virus Infection Is a Risk Factor for Severe Hepatic Cytolysis after Initiation of a Protease Inhibitor-Containing Antiretroviral Regimen in Human Immunodeficiency Virus-Infected Patients Antimicrobial Agents and Chemotherapy 44(12): 3451-3455
Vicente, V. 1989: Plasma concentrates of factor VIII. Where are we? Sangre 34(1): 1-3
Lusher, J.M. 1991: Thrombogenicity associated with factor IX complex concentrates Seminars in Hematology 28(3 Suppl 6: 3-5
Magner, A.; Aronson, D. 1979: Toxicity of factor IX concentrates in mice Developments in Biological Standardization 44: 185-188
Thomas, D.P. 1995: Clotting factor concentrated--whither purity? Thrombosis and Haemostasis 74(6): 1604-1606
Baldwin, R.D. 1964: The Diagnosis of Clotting Factor Deficiencies Journal of the Medical Society of New Jersey 61: 369-372
Klarmann, D.; Kreuz, W.; Auerswald, G.; Auberger, K.; Rabenau, H.; Gürtler, L.; Roggendorf, M. 1995: Hepatitis C and pasteurised factor VIIi and IX concentrates Thrombosis and Haemostasis 73(4): 736-737
Yoshioka, A.; Shima, M.; Nishino, M.; Yoshikawa, N.; Fukui, H. 1987: In vitro characterization of various factor VIII concentrates Arzneimittel-Forschung 37(7): 753-756
Kitchen, S.; Preston, F.E. 1993: Factor VIi clotting assays: influence of thromboplastin Thrombosis and Haemostasis 70(4): 720